| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1440-1746.1992.TB00927.X |
| P698 | PubMed publication ID | 1543863 |
| P2093 | author name string | K Shirai | |
| Y Saito | |||
| Y Mori | |||
| S Yoshida | |||
| M Wakashin | |||
| Y Shiki | |||
| P2860 | cites work | High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study | Q41115222 |
| BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO. | Q41943845 | ||
| Chronic aggressive hepatitis induced by halothane | Q42232630 | ||
| Biochemical study of anti-inflammatory and anti-arthritic properties of glycyrrhetic acid. | Q51249716 | ||
| Studies on the Mechanism of Galactosamine Hepatitis: Accumulation of Galactosamine-1-Phosphate and its Inhibition of UDP-Glucose Pyrophosphorylase | Q56681255 | ||
| P433 | issue | 1 | |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 12-16 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
| P1476 | title | Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody | |
| P478 | volume | 7 |
| Q35535475 | A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation |
| Q28534716 | Antiviral activity of glycyrrhizin against hepatitis C virus in vitro |
| Q36948453 | Antiviral effects of Glycyrrhiza species |
| Q39256029 | Comparative study to evaluate the anti-viral efficacy of Glycyrrhiza glabra extract and ribavirin against the Newcastle disease virus |
| Q44106949 | Effects of glycyrrhizin on glucocorticoid signaling pathway in hepatocytes |
| Q41368968 | Ethnopharmacological Approaches for Therapy of Jaundice: Part II. Highly Used Plant Species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae Families. |
| Q35203744 | Glycyrrhizin as antiviral agent against Hepatitis C Virus |
| Q46906851 | Glycyrrhizin attenuates endotoxin- induced acute liver injury after partial hepatectomy in rats |
| Q53061818 | Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine. |
| Q46771241 | Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice |
| Q36269281 | Herbal medicines for liver diseases |
| Q21284956 | Herbal products: benefits, limits, and applications in chronic liver disease |
| Q73085698 | Inhibition of human complement by beta-glycyrrhetinic acid |
| Q53112458 | Isolation of phlorotannins from Eisenia bicyclis and their hepatoprotective effect against oxidative stress induced by tert-butyl hyperoxide. |
| Q34186196 | Recent advances in herbal medicine for treatment of liver diseases |
| Q34466343 | Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. |
| Q34011396 | Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds |
| Q37105302 | Some Haematological and Biochemical Investigations on Duck Virus Hepatitis following Administration of Glycyrrhizin. |
| Q35663753 | The use of Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, in robust neuroprotection in the postischemic brain |
| Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
| Q37613544 | Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin-A Multicenter Study |
Search more.